-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ReNu in Osteoarthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ReNu in OsteoarthritisDrug Details:ReNu is under development of the treatment of knee osteoarthritis (OA), hip osteoarthritis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ReNu in Fasciitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ReNu in FasciitisDrug Details:ReNu is under development of the treatment of knee osteoarthritis (OA), hip osteoarthritis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Rubella (German Measles)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Rubella (German Measles)Drug Details:Vaccine candidate is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Measles
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in MeaslesDrug Details:Vaccine candidate is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QRA-244 in Amyotrophic Lateral Sclerosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QRA-244 in Amyotrophic Lateral Sclerosis Drug Details: QRA-244 is under development for the treatment...
-
Thematic Analysis
New![]()
Semiconductors Sector Scorecard, Q3 2023 Update – Thematic Intelligence
Companies scoring strongly in artificial intelligence (AI) and geopolitics-related themes lead the thematic screen of GlobalData’s semiconductors sector scorecard. Indeed, four themes (AI, AI chips, geopolitics, and China impact) jointly account for 50% of the weighting of the thematic screen, reflecting both the importance of AI, particularly generative AI, in the technology industry and the impact of the ongoing US-China trade dispute. The thematic ranking is led by companies with advanced AI products, such as Nvidia, Amazon, Tesla, and Alibaba,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SOT-102 in Adenocarcinoma Of The Gastroesophageal Junction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SOT-102 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:SON-102 is under development for the treatment of...
-
Thematic Analysis
New![]()
Synthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Track & Monitor
![]()
Innovation in technology: ECC memory
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the technology industry’s ECC memory innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience in...
-
Track & Monitor
![]()
Innovation in technology: PCI power mgmt.
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the technology industry’s PCI power mgmt. innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.